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 Solubility plays an important role in dissolution and absorption of 
drug. Paracetamol has less solubility in aqueous media and belongs to 
class IV drug according to biopharmaceutical classification 
system.The aim of present study was to study the effect of different 
solubility enhancing agents at room temperature on the solubility of 
paracetamol. Different solubility enhancing agents like  β-
cyclodextrin, Hydroxypropyl-β- cyclodextrin, mannitol, urea and 
Sodium Lauryl Sulphate (SLS) in various concentrations like 0.25 % 
w/v, 0.5 % w/v, 0.75 % w/v  and 1.0 % w/v were used to study the 
solubility of paracetamol in water as well as phosphate buffer pH 7.4 
system. 
 
Please cite this article in press as   Joshi HA et.al.  Effect Of Solubility Enhancers On The Solubility Of Paracetamol. Indo American 
Journal of Pharm Research.2012:2(11). 
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INTRODUCTION 
The oral rout of drug administration is most common and popular rout as it confers convenience, easy ingestion 
and patient compliance.
1
 The term solubility is defined as the maximum amount of the solute that can dissolve 
in given amount of solvent. It can also be defined qualitatively as well as quantitavely. Quantitatively it is 
defined as concentration of solute in a saturated solution at certain temperature and qualitative terms; it is 
defined as the spontaneous interaction of two or more substances to form a homogenous molecular dispersion. 
A saturated solution is one in which the solute is in equilibrium with the solvent Poorly aqueous soluble drugs 
are usually characterized by low bioavailability due to less absorption which is a major concern of 
pharmaceutical industries worldwide. Studies to improve the solubility of these drug candidates have been 
carried out with various techniques like micronization, chemical modification, pH adjustment, solid dispersion, 
complexation, co-solvency, micellar solubilization and hydrotrophy. 
2, 3
 
Paracetamol is a nonsteroidal analgesic and antipyretic drug with minimal side effects. It is freely soluble in 
ethanol (95%) and acetone; sparingly soluble in water, very slightly soluble in dichloromethane and ether.  The 
drug suffers from poor bioavailability because of its poor aqueous solubility. According to biopharmaceutical 
classification system (BCS) it belongs to class IV drug. Present study is carried out to investigate the carrier that 
improves the solubility of   paracetamol and thus bioavailability.
4,5
 
MATERIALS AND METHODS   
Materials 
Paracetamol, Urea, Mannitol and Sodium Lauryl Sulphate  (Research Lab, Pune ) procured from our institute,β-
cyclodextrin (β-CD), hydroxyl propyl-β-cyclodextrin HP-β-CD) purchased from S.D. Fine chemicals, 
Potassium di-hydrogen phosphate (AR  Grade), Sodium hydroxidepurchased from Loba Chemi Pune, Double 
distilled water freshly prepared and used.  
 
Methods 
Preparation of Standard Curve of Paracetamol Phosphate Buffer 
Standard curve of Paracetamol was plotted by dissolving 100 mg of drug in 100 ml phosphate buffer pH 7.4. 
1ml of the above solution was pipette out in 100 ml volumetric flask and diluted upto 100 ml. This solution 
served as the stock solution. From the stock solution 1ml, 2ml, 3ml, 4 ml upto 9 ml were transferred to 10 ml 
volumetric flask and diluted with phosphate buffer pH 7.4 upto mark to obtain the solution of concentration 1 
μg/ml, 2 μg/ml, 3 μg/ml,4 μg/ml upto 9 μg/ml respectively. The dilutions were sonicated for 10 minutes to 
remove air entrapped if any and analyzed for absorbance at 257 nm using UV- Spectrophotometer(Schimadzu 
UV 1700). 
4
 
 
Phase Solubility Study 
The phase solubility studies were carried out according to Higuchi and Connors. Briefly, an excess amount of 
paracetamol was added to the aqueous solutions (10 ml) of mannitol, urea, sodium lauryl sulphate (SLS),β-
cyclodextrin (β-CD) and hydroxyl propyl-β-cyclodextrin HP-β-CD) of varying concentrations (0.25 %w/v to 
1.0%w/v). The flasks were sealed and kept for 72 hours with constant shaking. After the equilibrium  reached 
the samples of each flask was filtered through Whatman filter paper no 40. The filtered solution was diluted 
with phosphate buffer pH 7.4 and analyzed by U.V. Spectrophometer (Schimadzu UV 1700).  The work study 
was carried out at room temperature.
6
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RESULT AND DISCUSSION 
Standard Curve for Paracetamol  
A Standard plot of paracetamol was plotted in the concentration range of 1 μg/ml to 10 μg/ml in phosphate 
buffer pH 7.4 with the absorbance measured at 257 nm. The calibration equation for the standard graph was 
found to be y=0.068x and the regression coefficient (R
2 =0.947) wasused in all calculations. The standard plot 
of paracetamol shown in figure1 
 
Table 1: Standard Curve For Paracetamol at pH 7.4 
Serial 
Number 
Concentration in 
[mcg/ml] 
Absorbance at 
257 nm 
1 0 0 
2 1 0.158 
3 2 0.188 
4 3 0.261 
5 4 0.295 
6 5 0.396 
7 6 0.401 
8 7 0.48 
9 8 0.532 
10 9 0.626 
11 10 0.625 
Table 2: Solubility of Paracetamol in Distilled Water 
Concentration 
of Solubility 
Enhancing 
Agent (% 
w/v) 
Solubility of Paracetamol in Distilled Water ( mg/ml) in 
presence of 
Mannitol Urea 
Sodium 
Lauryl 
Sulphate 
β-
Cyclodextrin 
(β-CD)  
Hydroxyl 
Propyl-β-
Cyclodextrin 
HP-β-CD)  
0 12.693 12.693 12.693 12.693 12.693 
0.25 12.2628 13.6642 19.9124 14.5401 25.5182 
0.5 17.6934 16.8759 20.9051 14.5985 26.2190 
0.75 17.8102 21.9562 21.1971 14.9489 26.5109 
1 18.6277 53.3139 21.8978 15.9416 29.8978 
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Table 3: Solubility of Paracetamol in Phosphate Buffer pH 7.4 
Concentration 
of Solubility 
Enhancing 
Agent (% 
w/v) 
Solubility of Paracetamol in Phosphate Buffer pH 7.4                                          
( mg/ml) in presence of 
Mannitol Urea 
Sodium 
Lauryl 
Sulphate 
β-
Cyclodextrin 
(β-CD)  
Hydroxyl 
Propyl-β-
Cyclodextrin 
HP-β-CD)  
0 13.69 13.69 13.69 13.69 13.69 
0.25 15.3577 14.1898 18.2190 11.1533 27.5036 
0.5 16.2336 15.2409 20.9051 13.7226 28.6131 
0.75 18.3942 16.8759 23.0657 14.1314 29.0803 
1 22.2482 17.5182 24.0584 15.0657 30.4818 
 
 
Figure 1: Standard Curve for Paracetamol at pH 7.4 
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Figure 2: Standard Curve for Paracetamol in Distilled Water 
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Figure 3: Standard Curve for Paracetamol in Phosphate Buffer pH 7.4 
Phase Solubility Study 
The introduction of Biopharmaceutical Classification (BCS) in 1995 was the result of continuous efforts on 
mathematical analysis for the elucidation of the kinetic and dynamics of the drug process in gastrointestinal 
tract (GI). The BCS is a scientific framework for classifying a drug substance based on its aqueous solubility 
and intestinal permeability. It allows for the prediction of in-vivo pharmacokinetics of oral immediate release 
(IR) drug products by classifying the drug entity either if four class. 
7
 According to the BCS system paracetamol 
belongs to class IV category indicating poor solubility and poor permeability.
5 
In the present study the solubility 
of paracetamol was found to be 12.963 mg/mlin distilled water and 13.786 mg/ml in phosphate buffer pH 7.4. 
The solubility data from literature survey was 13.69 mg/ml 
6
, 14.7 mg/ml at 20
0
 C, 14.3 mg/ml at 25
0
 C and 
23.7mg/ml at 37
0
 C.
8
The phase solubility study of paracetamol was carried out in presence of hydrophilic 
carriers like mannitol and urea, Complexing agents like β-cyclodextrin (β-CD) and hydroxyl propyl-β-
cyclodextrin (HP-β-CD) and surfactant SLS at different concentrations. The solubility in distilled water and 
phosphate buffer pH 7.4 increases gradually with increase in concentrations of mannitol, urea, SLS, β-CD, Hp-
β-CD. The maximum solubility in distilled water at 1%w/v of mannitol, urea, SLS, β-CD and Hp-β-CD was 
18.6277 mg/ml (1.46 fold), 53.3139mg/ml (4.2 fold), 21.8978 mg/ml (1.725 fold), 15.9416 mg/ml (1.25 fold) 
and 29.8978 mg/ml (2.35 fold) respectively. The maximum solubility inphosphate buffer pH 7.4 at 1%w/v of 
mannitol, urea, SLS, β-CD and Hp-β-CD was 22.2482 mg/ml (1.625 fold), 17.5182 mg/ml (1.27 fold), 24.0584 
mg/ml (1.75 fold), 15..657 mg/ml (1.1 fold) and 30.4818 mg/ml (2.22 fold) respectively. The results are 
presented Table 2 and 3 
CONCLUSION  
Amongst the various carriers used to improve the solubility of paracetamol, hydroxylpropyl-β-cyclodextrin 
(HP-β-CD) yielded most favorable results in terms of consistency and can be suitably used in immediate release 
(IR) and sustained release (SR) drug dosage forms of paracetamol. 
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